These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 6189585

  • 1. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F, Cadman E.
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [Abstract] [Full Text] [Related]

  • 2. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT, Craig RW, Agarwal RP.
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E, Eiferman F.
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [Abstract] [Full Text] [Related]

  • 7. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 8. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S, Cadman E.
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS, Occhipinti SJ, Cunningham RE, Shackney SE.
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells.
    Roberts D, Peck C, Hilliard S, Wingo W.
    Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642
    [Abstract] [Full Text] [Related]

  • 12. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ, Barnes DM, Fisher SG, Albain KS, Fisher RI, Erickson LC.
    Cancer Res; 1989 Mar 15; 49(6):1383-9. PubMed ID: 2924295
    [Abstract] [Full Text] [Related]

  • 13. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells.
    Bhalla K, Swerdlow P, Grant S.
    Blood; 1991 Dec 01; 78(11):2937-44. PubMed ID: 1954383
    [Abstract] [Full Text] [Related]

  • 14. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD, Akman SA, Joneckis CC, Yang E, Bachur NR.
    Cancer Res; 1984 Apr 01; 44(4):1530-5. PubMed ID: 6584206
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S, Lehman C, Cadman E.
    Cancer Res; 1980 May 01; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract] [Full Text] [Related]

  • 16. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul 01; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 18. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE, Straus MJ.
    Cancer Treat Rep; 1980 Jan 15; 64(1):81-6. PubMed ID: 7379059
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
    Swinnen LJ, Ellis NK, Erickson LC.
    Cancer Res; 1991 Apr 15; 51(8):1984-9. PubMed ID: 2009517
    [Abstract] [Full Text] [Related]

  • 20. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Kubota M, Takimoto T, Tanizawa A, Akiyama Y, Mikawa H.
    Biochem Pharmacol; 1988 May 01; 37(9):1745-9. PubMed ID: 2454114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.